GA NCORP

TRIALS & PROVIDERS

Menu

NCORP Trials

Cancer Type = Non-Hodgkin Lymphoma

1.
A Multi-Center, Randomized, Phase III Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma
Cancer Type
Non-Hodgkin Lymphoma
NCI ID
NCT00078598
Protocol IDs
CCBX001-049 (primary)
Treatment Sites (1)
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
2.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Cancer Type
Multiple Myeloma, Non-Hodgkin Lymphoma, Plasma cell neoplasm
NCI ID
NCT02693535
Protocol IDs
Pro00014171 (primary)
NCI-2017-00510
Treatment Sites (3)
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
For a complete listing of all trials matching your criteria in Georgia, please visit GeorgiaCancerInfo.org
1-2 of 2 Trials
CALL EMAIL

Copyright © 2015, Georgia NCI Community Oncology Research Program. All Rights Reserved.
Powered by GeorgiaCancerInfo.org
Website Design & Development by Peachtree Solutions.